GSK3B, glycogen synthase kinase 3 beta, 2932

N. diseases: 393; N. variants: 25
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030297
Disease: Pancreatic Neoplasm
Pancreatic Neoplasm
0.050 Biomarker disease BEFREE An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. 30144430 2018
CUI: C0030297
Disease: Pancreatic Neoplasm
Pancreatic Neoplasm
0.050 Biomarker disease LHGDN Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer. 18829575 2008
CUI: C0030297
Disease: Pancreatic Neoplasm
Pancreatic Neoplasm
0.050 Biomarker disease LHGDN Primers on molecular pathways. The glycogen synthase kinase-3beta. 17912008 2007
CUI: C0030297
Disease: Pancreatic Neoplasm
Pancreatic Neoplasm
0.050 AlteredExpression disease LHGDN Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. 16951223 2006
CUI: C0030297
Disease: Pancreatic Neoplasm
Pancreatic Neoplasm
0.050 Biomarker disease LHGDN GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells. 15609321 2005